Gordian Surgical
TroClose™: First in-class integrated trocar and closure device, streamlining laparoscopic port access and wound closure
TroClose™: First in-class integrated trocar and closure device, streamlining laparoscopic port access and wound closure
Gordian Surgical is a pioneering company in the biotechnology and healthcare industries, founded in 2012. The company's groundbreaking TroClose™ serves as an integrated trocar and closure device, streamlining laparoscopic port access and wound closure. This innovative product aims to enhance efficiency and improve patient outcomes in laparoscopic surgery. The device demonstrates a 75% reduction in tissue tension compared to manual suturing and traditional closure devices, underscoring its commitment to safety and ease of use. With a focus on research and development, Gordian Surgical has established a robust foundation and an active product pipeline. This commitment positions the company as a leader in advancing technology for laparoscopic and robotic surgeons, with its innovative solutions becoming essential in modern operating rooms. The company's most recent milestone includes a noteworthy $3.00M Venture Round investment on 29 October 2019, signifying investor confidence in its vision and potential impact on the healthcare industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $3.00M | - | 29 Oct 2019 | |
| Series A | $2.25M | 4 |
|
07 Dec 2016 |
| Seed Round | $1.00M | 2 |
|
20 Oct 2015 |
| Seed Round | $1.00M | - | 29 Apr 2014 |
No recent news or press coverage available for Gordian Surgical.
We care about your data, and we'd love to use cookies make your experience better.
